These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1759830)

  • 1. Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children.
    Kearns GL; Reed MD; Jacobs RF; Ardite M; Yogev RD; Blumer JL
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2078-84. PubMed ID: 1759830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.
    Kearns GL; Young RA
    Clin Pharmacokinet; 1994 Mar; 26(3):169-89. PubMed ID: 8194281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ceftibuten in children.
    Barr WH; Affrime M; Lin CC; Batra V
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S93-101. PubMed ID: 7567317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of ceftibuten in humans.
    Barr WH; Lin CC; Radwanski E; Lim J; Symchowicz S; Affrime M
    Diagn Microbiol Infect Dis; 1991; 14(1):93-100. PubMed ID: 2013216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ceftibuten-cis and its trans metabolite in healthy volunteers and in patients with chronic renal insufficiency.
    Kelloway JS; Awni WM; Lin CC; Lim J; Affrime MB; Keane WF; Matzke GR; Halstenson CE
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2267-74. PubMed ID: 1803999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny.
    Kearns GL; Robinson PK; Wilson JT; Wilson-Costello D; Knight GR; Ward RM; van den Anker JN;
    Clin Pharmacol Ther; 2003 Oct; 74(4):312-25. PubMed ID: 14534518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose pharmacokinetics of ceftibuten after oral administration to healthy volunteers.
    Bressolle F; Galtier M; Kinowski JM; Goncalves F; Edno L; Panis R; Gomeni R
    J Pharm Sci; 1994 Sep; 83(9):1236-40. PubMed ID: 7830237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftibuten: a new expanded-spectrum oral cephalosporin.
    Guay DR
    Ann Pharmacother; 1997 Sep; 31(9):1022-33. PubMed ID: 9296244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of ceftibuten into middle ear fluid.
    Lin C; Kumari P; Perrotta RJ; Reidenberg BE
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1394-6. PubMed ID: 8726007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of dapsone in human immunodeficiency virus-infected children.
    Gatti G; Loy A; Casazza R; Miletich F; Cruciani M; Bassetti D
    Antimicrob Agents Chemother; 1995 May; 39(5):1101-6. PubMed ID: 7625796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefepime in patients with thermal burn injury.
    Bonapace CR; White RL; Friedrich LV; Norcross ED; Bosso JA
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2848-54. PubMed ID: 10582870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children.
    Reed MD; Yamashita TS; Knupp CK; Veazey JM; Blumer JL
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1783-7. PubMed ID: 9257761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
    Mamzoridi K; Kasteridou N; Peonides A; Niopas I
    Pharmacol Toxicol; 1996 Jun; 78(6):417-20. PubMed ID: 8829204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
    Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
    Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftibuten: an overview.
    Owens RC; Nightingale CH; Nicolau DP
    Pharmacotherapy; 1997; 17(4):707-20. PubMed ID: 9250548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and dose proportionality of ceftibuten in men.
    Lin C; Lim J; Radwanski E; Marco A; Affrime M
    Antimicrob Agents Chemother; 1995 Feb; 39(2):359-61. PubMed ID: 7726498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of ceftibuten in bronchial secretions.
    Scaglione F; Triscari F; Demartini G; Arcidiacono M; Cocuzza C; Fraschini F
    Chemotherapy; 1995; 41(4):229-33. PubMed ID: 7555201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children.
    Blumer JL; Reed MD; Kearns GL; Jacobs RF; Gooch WM; Yogev R; Willims K; Ewing BJ
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1721-5. PubMed ID: 7486908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.